What is PRA Health Sciences 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-05), PRA Health Sciences's 12-1 Month Momentum % is 75.68%.
The industry rank for PRA Health Sciences's 12-1 Month Momentum % or its related term are showing as below:
PRAH's 12-1 Month Momentum % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -19.915
vs PRAH: 75.68
Competitive Comparison of PRA Health Sciences's 12-1 Month Momentum %
For the Diagnostics & Research subindustry, PRA Health Sciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRA Health Sciences's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PRA Health Sciences's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where PRA Health Sciences's 12-1 Month Momentum % falls into.
PRA Health Sciences (NAS:PRAH) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRA Health Sciences (NAS:PRAH) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
PRA Health Sciences 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of PRA Health Sciences's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
PRA Health Sciences (PRA Health Sciences) Business Description
PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. PRA's competitor, Icon, announced it will acquire PRA for $12 billion, which is scheduled to close in third-quarter 2021.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRAH has been successfully added to your